Skip to search formSkip to main contentSkip to account menu

RO 5072759

Known as: RO-5072759, RO5072759 
National Institutes of Health

Related topics

Related topics

2 relations
GA 101

Broader (1)

obinutuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20+ Malignant Disease (Phase I/II Study BO20999)
Abstract 1833 Background and Objective: GA101 is the first type II glycoengineered and humanized monoclonal anti-CD20 antibody to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)